The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Esperion Therapeutics Inc’s stock clocked out at $2.19, down -0.45% from its previous closing price of $2.20. In other words, the price has decreased by -$0.45 from its previous closing price. On the day, 5.09 million shares were traded. ESPR stock price reached its highest trading level at $2.22 during the session, while it also had its lowest trading level at $2.1001.
Ratios:
To gain a deeper understanding of ESPR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.37 and its Current Ratio is at 1.85.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on December 18, 2024, initiated with a Neutral rating and assigned the stock a target price of $4.
On December 17, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.
BofA Securities Downgraded its Neutral to Underperform on June 20, 2024, while the target price for the stock was maintained at $2.50.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 17 ’24 when Halladay Benjamin sold 3,245 shares for $2.42 per share. The transaction valued at 7,866 led to the insider holds 240,691 shares of the business.
Warren Eric sold 2,234 shares of ESPR for $5,426 on Dec 17 ’24. The Chief Commercial Officer now owns 160,121 shares after completing the transaction at $2.43 per share. On Dec 17 ’24, another insider, Koenig Sheldon L., who serves as the President and CEO of the company, sold 12,447 shares for $2.47 each. As a result, the insider received 30,694 and left with 739,819 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ESPR now has a Market Capitalization of 431506688 and an Enterprise Value of 555752000. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.45. Its current Enterprise Value per Revenue stands at 1.881 whereas that against EBITDA is 33.688.
Stock Price History:
Over the past 52 weeks, ESPR has reached a high of $3.94, while it has fallen to a 52-week low of $1.58. The 50-Day Moving Average of the stock is -9.92%, while the 200-Day Moving Average is calculated to be -2.30%.
Shares Statistics:
It appears that ESPR traded 5.67M shares on average per day over the past three months and 3932040 shares per day over the past ten days. A total of 195.44M shares are outstanding, with a floating share count of 195.08M. Insiders hold about 0.99% of the company’s shares, while institutions hold 65.87% stake in the company. Shares short for ESPR as of 1734048000 were 25474270 with a Short Ratio of 4.50, compared to 1731628800 on 31247976. Therefore, it implies a Short% of Shares Outstanding of 25474270 and a Short% of Float of 12.959999999999999.
